140
Participants
Start Date
March 31, 2015
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Suspected NASH BreathID test with 13C-Octanoate
Subject will have breath measured before and after ingestion of solution of 100 mg 13C Octanoate dissolved in 150 cc of water
Suspected NASH Breath test with 13C Methacetin
Subject will have breath measured before and after ingestion of solution of 75 mg 13C Methacetin dissolved in 150 cc of water
St. Mary's Hospital, Richmond
Virginia Commonwealth University, Richmond
Mary Immaculate Hospital, Newport News
Northwestern University, Feinberg School of Medicine, Chicago
Hôpital Pitié Salpêtrière, Paris
Baylor College of Medicine, Houston
Liver Associates, Houston
Texas Liver Institute, San Antonio
San Antonio Military Medical Center, Forts Sam Houston
Antwerp University Hospital (UZA), Edegem
Freeman Hospital, Newcastle
Lead Sponsor
Meridian Bioscience, Inc.
INDUSTRY